Safety study of two experimental drugs in healthy adults
Part of Heart & circulation clinical trials.
This study tests two new experimental drugs, AD-118 and AD-1181, in healthy adults to see if they are safe and how the body processes them. It helps researchers decide if further testing in patients is possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 64 years old.
- Your weight must be at least 50 kilograms (about 110 pounds).
- Your body mass index (BMI) must be between 18 and 30.
- You should not have taken part in another drug trial in the last 6 months.
- You must be in good general health (other screening tests may apply).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two new drugs, AD-118 and AD-1181, to see if they are safe and how the body handles them. It is for healthy volunteers to gather early information before testing in patients.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This trial compares how the body processes two different forms of the same drug, AD-117 and AD-117A, and checks for safety. It's for healthy adults to help ensure the drug works similarly and safely.
This trial tests a new drug (AD-115A or AD-1151) in healthy volunteers to see how safe it is and how the body processes it. If you qualify, you'll receive a single dose and be monitored closely.
This trial studies how two experimental drugs (AD-2321 and AD-2322) interact in the body and if they are safe for healthy volunteers. It is a Phase 1 study open to healthy adults.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.